Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma of Lung 4Lung Neoplasms 3Esophageal Neoplasms 3Mouth Neoplasms 2Head and Neck Neoplasms 2Barrett Esophagus 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Neoplasms 1Salivary Gland Neoplasms 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Laryngeal Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Basal Cell 1Adenocarcinoma, Follicular 1Adenocarcinoma Of Esophagus 1

Interventions

Nivolumab 13Ipilimumab 10pembrolizumab 8cemiplimab 6Surveys and Questionnaires 6Biopsy 6aldesleukin 5Radiotherapy 5Interleukin-2 5Blood Specimen Collection 5Temozolomide 4Sirolimus 4Photochemotherapy 4Mohs Surgery 4HhAntag691 4Fluorouracil 4Educational Status 4Cyclophosphamide 4sonidegib 3fludarabine phosphate 3fludarabine 3avelumab 3Vemurafenib 3Surgical Procedures, Operative 3Radiation 3Petrolatum 3Cetuximab 3Aminolevulinic Acid 3trametinib 2dabrafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Skin Neoplasms × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT00017485 2011-03-07

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Roswell Park Cancer Institute

Phase 1 Completed
6 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡